首页> 外文期刊>International Journal of Pharmaceutics >Tuning drug loading and release properties of diatom silica microparticles by surface modifications
【24h】

Tuning drug loading and release properties of diatom silica microparticles by surface modifications

机译:通过表面改性调节硅藻土二氧化硅微粒的载药量和释放性能

获取原文
获取原文并翻译 | 示例
           

摘要

Diatomaceous earth (DE), or diatomite silica microparticles originated from fossilized diatoms are a potential substitute for its silica-based synthetic counterparts to address limitations in conventional drug delivery. This study presents the impact of engineered surface chemistry of DE microparticles on their drug loading and release properties. Surface modifications with four silanes, including 3-aminopropyltriethoxy silane (APTES), methoxy-poly- (ethylene-glycol)-silane (mPEG-silane), 7-octadecyltrichlorosilane (OTS), 3-(glycidyloxypropyl)trimethoxysilane (GPTMS) and two phosphonic acids, namely 2-carboxyethyl-phosphonic acid (2 CEPA) and 16-phosphono-hexadecanoic acid (16 PHA) were explored in order to tune drug loading and release characteristics of water insoluble (indomethacin) and water soluble drugs (gentamicin). Successful grafting of these functional groups with different interfacial properties was confirmed using X-ray photoelectron spectroscopy (XPS) and Fourier transform infrared spectroscopy (FTIR). Thermogravimetric analysis (TGA) was applied to determine the amount of loaded drugs and UV-spectrophotometry to analyse in vitro drug release from modified DE microparticles. Differences in drug release time (13-26 days) and loading capacity (14-24%) were observed depending on functional groups on the surface of DE microparticles. It was found that hydrophilic surfaces, due to the presence of polar carboxyl, amine or hydrolyzed epoxy group, favor extended release of indomethacin, while the hydrophobic DE surface modified by organic hydrocarbons gives a better sustained release profile for gentamicin. This work demonstrates that by changing surface functionalities on DE microparticles, it is possible to tune their drug loading and release characteristics for both hydrophobic and hydrophilic drugs and therefore achieve optimal drug delivery performance.? 2012 Elsevier B.V. All rights reserved.
机译:硅藻土(DE)或源自化石硅藻的硅藻土二氧化硅微粒可替代其基于二氧化硅的合成对等物,以解决常规药物输送中的局限性。这项研究提出了DE微粒的工程表面化学对其药物负载和释放特性的影响。用四种硅烷进行表面改性,包括3-氨基丙基三乙氧基硅烷(APTES),甲氧基-聚(乙二醇)-硅烷(mPEG-硅烷),7-十八烷基三氯硅烷(OTS),3-(环氧丙氧基丙基)三甲氧基硅烷(GPTMS)和两种研究了膦酸,即2-羧乙基膦酸(2 CEPA)和16-膦酰基十六烷酸(16 PHA),以调节水不溶性(吲哚美辛)和水溶性药物(庆大霉素)的载药量和释放特性。使用X射线光电子能谱(XPS)和傅里叶变换红外光谱(FTIR)证实了具有不同界面性质的这些官能团的成功接枝。应用热重分析(TGA)确定载药量,并使用紫外分光光度法分析改性DE微粒的体外药物释放。根据DE微粒表面上的官能团,观察到药物释放时间(13-26天)和载药量(14-24%)的差异。发现由于极性羧基,胺或水解的环氧基的存在,亲水性表面有利于消炎痛的延长释放,而由有机烃改性的疏水性DE表面为庆大霉素提供了更好的持续释放特性。这项工作表明,通过改变DE微粒的表面功能,可以调节疏水和亲水药物的载药量和释放特性,从而实现最佳的药物输送性能。 2012 Elsevier B.V.保留所有权利。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号